In a prospective study involving 318 TB patients undergoing anti-TB therapy, those with the homozygous wild-type CYP2E1 C1/C1 genotype were found to have a significantly higher risk of developing DILI compared to carriers of the mutant C2 allele. The gene discussed is CYP2E1; the disease is tuberculosis.